Search

Craig D. Ricci

Examiner (ID: 6907, Phone: (571)270-5864 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1611, 1628, 1614
Total Applications
1601
Issued Applications
776
Pending Applications
153
Abandoned Applications
697

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18149627 [patent_doc_number] => 20230023484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => DEPOT ADMINISTRATION OF ILOPERIDONE [patent_app_type] => utility [patent_app_number] => 17/935911 [patent_app_country] => US [patent_app_date] => 2022-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6489 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935911 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/935911
DEPOT ADMINISTRATION OF ILOPERIDONE Sep 26, 2022 Abandoned
Array ( [id] => 20466613 [patent_doc_number] => 12522646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => Activin receptor type II chimeras and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/945299 [patent_app_country] => US [patent_app_date] => 2022-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 51459 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17945299 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/945299
Activin receptor type II chimeras and methods of use thereof Sep 14, 2022 Issued
Array ( [id] => 20848318 [patent_doc_number] => 12685331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-21 [patent_title] => Nutritional compositions and infant formula for promoting de novo myealination [patent_app_type] => utility [patent_app_number] => 17/943652 [patent_app_country] => US [patent_app_date] => 2022-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 67 [patent_no_of_words] => 20037 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943652 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/943652
NUTRITIONAL COMPOSITIONS AND INFANT FORMULA FOR PROMOTING DE NOVO MYEALINATION Sep 12, 2022 Issued
Array ( [id] => 20371265 [patent_doc_number] => 12478680 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Hydrogels with biodegradable crosslinking [patent_app_type] => utility [patent_app_number] => 17/930381 [patent_app_country] => US [patent_app_date] => 2022-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 11353 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 623 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930381 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/930381
Hydrogels with biodegradable crosslinking Sep 6, 2022 Issued
Array ( [id] => 18285418 [patent_doc_number] => 20230100890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => USE OF COMBINED INHALANT CANNABINOID THERAPY IN THE TREATMENT OF MIGRAINE [patent_app_type] => utility [patent_app_number] => 17/930218 [patent_app_country] => US [patent_app_date] => 2022-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19801 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930218 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/930218
USE OF COMBINED INHALANT CANNABINOID THERAPY IN THE TREATMENT OF MIGRAINE Sep 6, 2022 Abandoned
Array ( [id] => 18108023 [patent_doc_number] => 20230000903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => METHODS AND SYSTEMS FOR NITRIC OXIDE THERAPY FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/929511 [patent_app_country] => US [patent_app_date] => 2022-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24805 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929511 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/929511
METHODS AND SYSTEMS FOR NITRIC OXIDE THERAPY FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS Sep 1, 2022 Pending
Array ( [id] => 18451493 [patent_doc_number] => 20230192771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => CYCLOSPORINE COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/891351 [patent_app_country] => US [patent_app_date] => 2022-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17194 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17891351 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/891351
Cyclosporine compositions and methods of use Aug 18, 2022 Issued
Array ( [id] => 19526508 [patent_doc_number] => 20240350410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 18/683535 [patent_app_country] => US [patent_app_date] => 2022-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40681 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18683535 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/683535
FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF Aug 15, 2022 Pending
Array ( [id] => 19380873 [patent_doc_number] => 20240270743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => TETRAHYDROPYRAZOLOPYRIDINE-ANALOG LIGANDS OF NLRX1 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/682563 [patent_app_country] => US [patent_app_date] => 2022-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18044 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682563 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/682563
TETRAHYDROPYRAZOLOPYRIDINE-ANALOG LIGANDS OF NLRX1 AND USES THEREOF Aug 8, 2022 Pending
Array ( [id] => 18250426 [patent_doc_number] => 20230077465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => LOW DOSE PRODUCT AND METHOD FOR TREATING DIARRHEA [patent_app_type] => utility [patent_app_number] => 17/884403 [patent_app_country] => US [patent_app_date] => 2022-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5977 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/884403
LOW DOSE PRODUCT AND METHOD FOR TREATING DIARRHEA Aug 8, 2022 Abandoned
Array ( [id] => 20067022 [patent_doc_number] => 20250205244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => METHODS OF TREATING MIGRAINE WITH MNK INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/294823 [patent_app_country] => US [patent_app_date] => 2022-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37646 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294823 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/294823
METHODS OF TREATING MIGRAINE WITH MNK INHIBITORS Aug 4, 2022 Pending
Array ( [id] => 20535712 [patent_doc_number] => 12552776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-17 [patent_title] => Crystalline forms [patent_app_type] => utility [patent_app_number] => 18/291712 [patent_app_country] => US [patent_app_date] => 2022-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 8970 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18291712 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/291712
Crystalline forms Jul 31, 2022 Issued
Array ( [id] => 19541603 [patent_doc_number] => 20240358639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => NANOPARTICLES FOR CANCER TREATMENT [patent_app_type] => utility [patent_app_number] => 18/577129 [patent_app_country] => US [patent_app_date] => 2022-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6853 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18577129 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/577129
NANOPARTICLES FOR CANCER TREATMENT Jul 6, 2022 Abandoned
Array ( [id] => 18565584 [patent_doc_number] => 20230255911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => COMPOSITIONS OF BIOACTIVE FULVATE FRACTIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/810805 [patent_app_country] => US [patent_app_date] => 2022-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25612 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810805 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/810805
COMPOSITIONS OF BIOACTIVE FULVATE FRACTIONS AND USES THEREOF Jul 4, 2022 Abandoned
Array ( [id] => 18374324 [patent_doc_number] => 20230149403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => CARBONIC ANHYDRASE ENZYMES FOR REGULATING MAST CELL HEMATOPOIESIS AND TYPE 2 INFLAMMATION [patent_app_type] => utility [patent_app_number] => 17/855501 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13363 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855501 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/855501
Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation Jun 29, 2022 Issued
Array ( [id] => 17928250 [patent_doc_number] => 20220323375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY [patent_app_type] => utility [patent_app_number] => 17/853367 [patent_app_country] => US [patent_app_date] => 2022-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5159 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17853367 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/853367
USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY Jun 28, 2022 Abandoned
Array ( [id] => 17959994 [patent_doc_number] => 20220340574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTS [patent_app_type] => utility [patent_app_number] => 17/850198 [patent_app_country] => US [patent_app_date] => 2022-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850198 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/850198
Solid polymorphs of a FLNA-binding compound and its hydrochloride salts Jun 26, 2022 Issued
Array ( [id] => 18842475 [patent_doc_number] => 20230404879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => ENHANCING PHOTOSTABILITY OF THIOPYRIDINONE COMPOUND WITHOUT THE USE OF UV FILTERS [patent_app_type] => utility [patent_app_number] => 17/844934 [patent_app_country] => US [patent_app_date] => 2022-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7843 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844934 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/844934
Enhancing photostability of thiopyridinone compound without the use of UV filters Jun 20, 2022 Issued
Array ( [id] => 17911471 [patent_doc_number] => 20220313866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => HYALURONIC ACID DERIVATIVE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/842475 [patent_app_country] => US [patent_app_date] => 2022-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12894 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842475 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/842475
HYALURONIC ACID DERIVATIVE AND USE THEREOF Jun 15, 2022 Abandoned
Array ( [id] => 21009835 [patent_doc_number] => 12746306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-09-29 [patent_title] => Hyaluronic acid derivative and use thereof [patent_app_type] => utility [patent_app_number] => 17/842493 [patent_app_country] => US [patent_app_date] => 2022-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 73 [patent_no_of_words] => 7808 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842493 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/842493
HYALURONIC ACID DERIVATIVE AND USE THEREOF Jun 15, 2022 Pending
Menu